[go: up one dir, main page]

SE0201660D0 - Pharmaceutical formulation - Google Patents

Pharmaceutical formulation

Info

Publication number
SE0201660D0
SE0201660D0 SE0201660A SE0201660A SE0201660D0 SE 0201660 D0 SE0201660 D0 SE 0201660D0 SE 0201660 A SE0201660 A SE 0201660A SE 0201660 A SE0201660 A SE 0201660A SE 0201660 D0 SE0201660 D0 SE 0201660D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical formulation
formulation
pharmaceutical
Prior art date
Application number
SE0201660A
Other languages
Swedish (sv)
Inventor
Cynthia Gaik-Lim-Khoo
Helena Gustafsson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0201660A priority Critical patent/SE0201660D0/en
Publication of SE0201660D0 publication Critical patent/SE0201660D0/en
Priority to ARP020102278A priority patent/AR034517A1/en
Priority to KR10-2003-7016620A priority patent/KR20040011542A/en
Priority to CNA028125347A priority patent/CN1518462A/en
Priority to DE60208369T priority patent/DE60208369T2/en
Priority to EP02744027A priority patent/EP1401502B1/en
Priority to MXPA03011546A priority patent/MXPA03011546A/en
Priority to US10/481,232 priority patent/US7700582B2/en
Priority to AT02744027T priority patent/ATE314093T1/en
Priority to RU2003136155/15A priority patent/RU2323006C2/en
Priority to AU2002345463A priority patent/AU2002345463B2/en
Priority to BR0210489-0A priority patent/BR0210489A/en
Priority to JP2003506935A priority patent/JP2005501024A/en
Priority to CZ20033491A priority patent/CZ299859B6/en
Priority to ES02744027T priority patent/ES2254699T3/en
Priority to HU0400850A priority patent/HUP0400850A3/en
Priority to PCT/SE2002/001217 priority patent/WO2003000293A1/en
Priority to SI200230264T priority patent/SI1401502T1/en
Priority to UA20031211097A priority patent/UA77959C2/en
Priority to PL02366432A priority patent/PL366432A1/en
Priority to IL15921702A priority patent/IL159217A0/en
Priority to NZ530086A priority patent/NZ530086A/en
Priority to CA002450449A priority patent/CA2450449A1/en
Priority to DK02744027T priority patent/DK1401502T3/en
Priority to SK1591-2003A priority patent/SK286238B6/en
Priority to MYPI20022304A priority patent/MY130332A/en
Priority to EEP200400028A priority patent/EE200400028A/en
Priority to ZA200309316A priority patent/ZA200309316B/en
Priority to IL159217A priority patent/IL159217A/en
Priority to NO20035627A priority patent/NO20035627D0/en
Priority to IS7081A priority patent/IS2347B/en
Priority to CO03110716A priority patent/CO5550466A2/en
Priority to BG108516A priority patent/BG108516A/en

Links

SE0201660A 2001-06-21 2002-05-31 Pharmaceutical formulation SE0201660D0 (en)

Priority Applications (33)

Application Number Priority Date Filing Date Title
SE0201660A SE0201660D0 (en) 2002-05-31 2002-05-31 Pharmaceutical formulation
ARP020102278A AR034517A1 (en) 2001-06-21 2002-06-18 PHARMACEUTICAL FORMULATION
EEP200400028A EE200400028A (en) 2001-06-21 2002-06-19 Pharmaceutical preparation, method of its preparation and its use in medicine
ES02744027T ES2254699T3 (en) 2001-06-21 2002-06-19 PHARMACEUTICAL FORMULATION THAT INCLUDES IOTA-CARRAGENAN AND AT LEAST A NEUTRAL GELIFYING POLYMER.
SI200230264T SI1401502T1 (en) 2001-06-21 2002-06-19 Pharmaceutical formulation comprising iota-carrageenan and at least one neutral gelling polymer
DE60208369T DE60208369T2 (en) 2001-06-21 2002-06-19 A pharmaceutical formulation containing IOTA carrageenan and at least one gel-forming neutral polymer
EP02744027A EP1401502B1 (en) 2001-06-21 2002-06-19 Pharmaceutical formulation comprising iota-carrageenan and at least one neutral gelling polymer
MXPA03011546A MXPA03011546A (en) 2001-06-21 2002-06-19 New use.
US10/481,232 US7700582B2 (en) 2001-06-21 2002-06-19 Pharmaceutical formulation
AT02744027T ATE314093T1 (en) 2001-06-21 2002-06-19 PHARMACEUTICAL FORMULATION CONTAINING IOTA CARRAGEENAN AND AT LEAST ONE GEL-FORMING NEUTRAL POLYMER
RU2003136155/15A RU2323006C2 (en) 2001-06-21 2002-06-19 Pharmaceutical composition
AU2002345463A AU2002345463B2 (en) 2001-06-21 2002-06-19 Pharmaceutical formulation
BR0210489-0A BR0210489A (en) 2001-06-21 2002-06-19 Oral pharmaceutical formulation, process for preparing it, use of the table, and method for preparing a cardiovascular disorder in a patient
JP2003506935A JP2005501024A (en) 2001-06-21 2002-06-19 Pharmaceutical formulation
CZ20033491A CZ299859B6 (en) 2001-06-21 2002-06-19 Pharmaceutical formulation and process for its preparation
KR10-2003-7016620A KR20040011542A (en) 2001-06-21 2002-06-19 Pharmaceutical Formulation
HU0400850A HUP0400850A3 (en) 2001-06-21 2002-06-19 Oral pharmaceutical compositions
PCT/SE2002/001217 WO2003000293A1 (en) 2001-06-21 2002-06-19 Pharmaceutical formulation
CNA028125347A CN1518462A (en) 2001-06-21 2002-06-19 pharmaceutical preparation
UA20031211097A UA77959C2 (en) 2001-06-21 2002-06-19 Pharmaceutical formulation comprising iota-carrageenan and neutral gelling polymer, process for manufacture and use
PL02366432A PL366432A1 (en) 2001-06-21 2002-06-19 Pharmaceutical formulation
IL15921702A IL159217A0 (en) 2001-06-21 2002-06-19 An oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine
NZ530086A NZ530086A (en) 2001-06-21 2002-06-19 Pharmaceutical formulation
CA002450449A CA2450449A1 (en) 2001-06-21 2002-06-19 Pharmaceutical formulation
DK02744027T DK1401502T3 (en) 2001-06-21 2002-06-19 A pharmaceutical formulation comprising iota-carrageenan and at least one neutral gelling polymer
SK1591-2003A SK286238B6 (en) 2001-06-21 2002-06-19 Pharmaceutical formulation comprising iota-carrageenan and method for preparation thereof
MYPI20022304A MY130332A (en) 2001-06-21 2002-06-19 Pharmaceutical formulation comprising iota-carrageenan and at least one neutral gelling polymer
ZA200309316A ZA200309316B (en) 2001-06-21 2003-11-28 Pharmaceutical formulation.
IL159217A IL159217A (en) 2001-06-21 2003-12-07 Oral pharmaceutical formulation comprising a basic pharmaceutically active ingredient having ph-dependent solubility, a process for the manufacture thereof and use thereof in medicine
NO20035627A NO20035627D0 (en) 2001-06-21 2003-12-15 Pharmaceutical formulation
IS7081A IS2347B (en) 2001-06-21 2003-12-16 Oral oral formulations comprising iota-carrageenan, one or more neutral gelling polymers and a basic pharmaceutical ingredient; wherein the mixture inhibits the release of the basic pharmaceutically active ingredient from the mixture at acidic pH.
CO03110716A CO5550466A2 (en) 2001-06-21 2003-12-18 PHARMACEUTICAL FORMULATION
BG108516A BG108516A (en) 2001-06-21 2004-01-06 Pharmaceutical formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0201660A SE0201660D0 (en) 2002-05-31 2002-05-31 Pharmaceutical formulation

Publications (1)

Publication Number Publication Date
SE0201660D0 true SE0201660D0 (en) 2002-05-31

Family

ID=20288038

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0201660A SE0201660D0 (en) 2001-06-21 2002-05-31 Pharmaceutical formulation

Country Status (1)

Country Link
SE (1) SE0201660D0 (en)

Similar Documents

Publication Publication Date Title
PT1501534E (en) PHARMACEUTICAL FORMULATIONS
NO20033384D0 (en) Pharmaceutical formulation
DK3536344T3 (en) SUPERFIN FORMOTHER FORMULATION
KR20050009999A (en) Pharmaceutical preparations
NO20033785L (en) Pharmaceutical formulation
NO20033556L (en) Pharmaceutical Formulations
FI20011478A0 (en) Pharmaceutical composition
ATE336264T1 (en) DISPERSIBLE PHARMACEUTICAL COMPOSITIONS
DE602004017700D1 (en) TRANSMUKOSEN ADMINISTRATION
PT1467724E (en) AGOMELATIN ORODISPERSAVEL PHARMACEUTICAL COMPOSITION
NO20035627D0 (en) Pharmaceutical formulation
DK1587478T3 (en) PHARMACEUTICAL COMPOSITION
DK1596870T3 (en) High-dose inter-radonate formulation
FI20022128A7 (en) Pharmaceutical composition
NO20043576L (en) Pharmaceutical formulation comprising melatonin
NO20041485L (en) Pharmaceutical formulation comprising (R) -bicalutamide
NO20034952D0 (en) Pharmaceutical compounds
NO20044164L (en) Pharmaceutical compositions
SE0200449D0 (en) Pharmaceutical formulation
SE0201660D0 (en) Pharmaceutical formulation
DE112004001429D2 (en) Pharmaceutical agent
NO20041236L (en) Pharmaceutical Formulation
SE0101325D0 (en) Pharmaceutical formulation
SE0101326D0 (en) Pharmaceutical formulation
SE0102069D0 (en) Pharmaceutical formulation